Comparison of sodium pentobarbitone and urethane anaesthesia in a rat model of coronary artery occlusion and reperfusion arrhythmias: Interaction with L-NAME

Pharmacological Research

Volumn 33, Issue 1, 1996, Pages 13-18

  Iskit, Alper B ^a   Guc, M Oguz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anaesthesia; L NAME; Reperfusion arrhythmias

Indexed keywords

ANESTHETIC AGENT; ARGININE METHYL ESTER; NITRIC OXIDE; PENTOBARBITAL; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029956334     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0003     Document Type: Article

References (24)

1. 1. Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR. Coronary artery ligation in anaesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods 1980; 3: 357-68.
2. 2. Dai S. Anaesthetic-related occurrence of early ventricular arrhythmias during acute myocardial ischaemia in rats. Arch Int Physiol Biochim 1989; 97: 341-46.
3. 2, propranolol and nitroglycerine with halothane, pethidin or pentobarbitone anaesthesia on arrhythmias and other responses to ligation of acoronary artery in rats. Br J Pharmacol 1983; 79: 929-37.
4. 4. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parrat JR, Riemersma RA, Riva E, Russel DC, Sheridan DJ, Winslow E, Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovascular Res 1988; 22: 447-55.
5. 5. Altura BM, Weinberg J. Urethane and contraction of vascular smooth muscle. Br J Pharmacol 1979; 67: 255-63.
6. ++ mobilization from both intra and extracellular pools. Experientia 1984; 40: 52-9.
7. 7. Armstrong JM, Lefevre-Borg F, Scatton B, Cavero I. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2-adrenoceptors in the rat. J Pharmacol Exp Ther 1982; 223: 524-35.
8. 8. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-64.
9. 9. Johnson III G, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia and reperfusion. Crit Care Med 1991; 19: 244-52.
10. 10. Siegfried MR, Erhardt J, Rider T, Xin-Liang MA, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992; 260: 668-75.
11. 11. Johnson III G, Tsao PS, Lefer AM. Synergism between Superoxide dismutase and sodium nitrite in cardioprotection following ischaemia and reperfusion. Am Heart J 1990; 119: 530-7.
12. 12. Masini E, Gambassi F, Bianchi S, Mugnai L, Lupini M, Pistelli A, Manaioni PF. Effect of nitric oxide generators on ischemia reperfusion injury and histamine release in isolated perfused guinea-pig heart. Int Arch Allergy Appl Immunol 1991; 94: 257-8.
13. 13. Vegh A, Szekeres L, Parratt JR. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 1992; 107: 448-52.
14. 14. Coker SJ, Barnes CS. Effects of the nitric oxide donor SIN-1 on haemodynamics, ischaemia-induced arrhythmias and cardiac cyclic nucleotides. Br J Pharmacol 1993; 109: 43P.
15. 15. Pabla R, Curtis MJ. Pro-arrhythmic effects of L-NAME on reperfusion-induced ventricular fibrillation depend upon the duration of preceeding ischaemia. J Physiol-London 1994; 475P: 63P-4P.
16. 16. Guc MO, Boachie-Ansah G, Kane KA, Wadsworth RM. Comparison of antiarrhythmic and electrophysiologic effects of diltiazem and its analogue siratiazem. J Cardiovasc Pharmacol 1993; 27: 681-6.
17. G-nitro-L-arginine methyl ester in conscious Long Evans rats. Br J Pharmacol 1990; 101: 625-31.
18. 18. Guc MO. Vascular responsiveness to vasoactive agents in endotoxaemia. PhD thesis. University of Strathclyde, 1992.
19. 19. Lepran I, Parratt JR, Szekeres L, Wainwright CL. The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats. Br J Pharmacol 1985; 86: 229-34.
20. 20. Patel VC, Woolfson RG, Neild GH, Yellon DM. Reduction of infarct size by L-NAME can be prevented by pretreatment with an adenosine antagonist in rabbit isolated hearts. Br J Pharmacol 1993; 108: 124P.
21. 21. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nature Med 1995; 1: 804-9.
22. 22. Southan GJ, Szabo C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995; 114: 510-16.
23. 23. Zambetis M, Dusting GJ, Rajanayagam S, Woodman OL. Mechanism of hypertension produced by inhibition of nitric oxide biosynthesis in rats. J Cardiovasc Pharmacol 1991; 17: 191-7.
24. G-nitro-L-arginine methyl ester administration. J Cardiovasc Pharmacol 1994; 23: 765-71.